Benzinga’s Top Upgrades (AET, HGSI, KBR, TOL, WYN)
October 30, 2009 11:13 AM
Aetna Inc. (Public, NYSE: AET) JP Morgan upgrades AET from Neutral to Overweight. AET is now trading at $26.62, 0.02% down. The stock has recovered over 80% from its 52-week low of %14.21.
Human Genome Sciences (Public, NASDAQ: HGSI) JP Morgan also upgraded HGSI to Overweight from Neutral, and raised their price target to $25 from $14.The stock is now up 0.62% at $20.11.
KBR, Inc. (Public, NYSE: KBR) climbed 1% to $20.73. Today Stifel Nicolaus upgrades KBR Buy from Hold. KBR has recovered over 120% from its 52-week lows of $9.78.
Toll Brothers, Inc. (Public, NYSE: TOL) increased 2.32% to $17.62 after Citi Upgrades Toll Brothers (TOL) to Buy.
Wyndham Worldwide Corporation (Public, NYSE: WYN) FBR Research upgrades WYN to Outperform with a price target $23. Now the stock is down 1.80% at $17.53.
